227 related articles for article (PubMed ID: 27019073)
1. Sfrp5 associates with beta-cell function in humans.
Carstensen-Kirberg M; Hatziagelaki E; Tsiavou A; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M; Herder C
Eur J Clin Invest; 2016 Jun; 46(6):535-43. PubMed ID: 27019073
[TBL] [Abstract][Full Text] [Related]
2. Circulating SFRP5 levels are elevated in drug-naïve recently diagnosed type 2 diabetic patients as compared with prediabetic subjects and controls.
Canivell S; Rebuffat S; Ruano EG; Kostov B; Sisó-Almirall A; Novials A; Ceriello A; Gomis R
Diabetes Metab Res Rev; 2015 Feb; 31(2):212-9. PubMed ID: 25139699
[TBL] [Abstract][Full Text] [Related]
3. Circulating Sfrp5 is a signature of obesity-related metabolic disorders and is regulated by glucose and liraglutide in humans.
Hu W; Li L; Yang M; Luo X; Ran W; Liu D; Xiong Z; Liu H; Yang G
J Clin Endocrinol Metab; 2013 Jan; 98(1):290-8. PubMed ID: 23185036
[TBL] [Abstract][Full Text] [Related]
4. Inverse associations between serum levels of secreted frizzled-related protein-5 (SFRP5) and multiple cardiometabolic risk factors: KORA F4 study.
Carstensen-Kirberg M; Kannenberg JM; Huth C; Meisinger C; Koenig W; Heier M; Peters A; Rathmann W; Roden M; Herder C; Thorand B
Cardiovasc Diabetol; 2017 Aug; 16(1):109. PubMed ID: 28851362
[TBL] [Abstract][Full Text] [Related]
5. Postprandial serum C-peptide to plasma glucose concentration ratio correlates with oral glucose tolerance test- and glucose clamp-based disposition indexes.
Okuno Y; Komada H; Sakaguchi K; Nakamura T; Hashimoto N; Hirota Y; Ogawa W; Seino S
Metabolism; 2013 Oct; 62(10):1470-6. PubMed ID: 23831440
[TBL] [Abstract][Full Text] [Related]
6. Serum Chemerin Concentrations Associate with Beta-Cell Function, but Not with Insulin Resistance in Individuals with Non-Alcoholic Fatty Liver Disease (NAFLD).
Hatziagelaki E; Herder C; Tsiavou A; Teichert T; Chounta A; Nowotny P; Pacini G; Dimitriadis G; Roden M
PLoS One; 2015; 10(5):e0124935. PubMed ID: 25933030
[TBL] [Abstract][Full Text] [Related]
7. Relationship between fatty liver and glucose metabolism: a cross-sectional study in 571 obese children.
Bedogni G; Gastaldelli A; Manco M; De Col A; Agosti F; Tiribelli C; Sartorio A
Nutr Metab Cardiovasc Dis; 2012 Feb; 22(2):120-6. PubMed ID: 20880682
[TBL] [Abstract][Full Text] [Related]
8. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
9. Plasma SFRP5 levels are decreased in Chinese subjects with obesity and type 2 diabetes and negatively correlated with parameters of insulin resistance.
Hu Z; Deng H; Qu H
Diabetes Res Clin Pract; 2013 Mar; 99(3):391-5. PubMed ID: 23290274
[TBL] [Abstract][Full Text] [Related]
10. Sfrp5 correlates with insulin resistance and oxidative stress.
Carstensen M; Herder C; Kempf K; Erlund I; Martin S; Koenig W; Sundvall J; Bidel S; Kuha S; Roden M; Tuomilehto J
Eur J Clin Invest; 2013 Apr; 43(4):350-7. PubMed ID: 23398169
[TBL] [Abstract][Full Text] [Related]
11. Effects of sugar-sweetened beverage intake on the development of type 2 diabetes mellitus in subjects with impaired glucose tolerance: the Mihama diabetes prevention study.
Teshima N; Shimo M; Miyazawa K; Konegawa S; Matsumoto A; Onishi Y; Sasaki R; Suzuki T; Yano Y; Matsumoto K; Yamada T; Gabazza EC; Takei Y; Sumida Y
J Nutr Sci Vitaminol (Tokyo); 2015; 61(1):14-9. PubMed ID: 25994135
[TBL] [Abstract][Full Text] [Related]
12. Associations Between Serum 25-Hydroxyvitamin D, Insulin Sensitivity, Insulin Secretion, and β-Cell Function According to Glucose Tolerance Status.
Morisset AS; Tardio V; Weisnagel J; Lemieux S; Bergeron J; Gagnon C
Metab Syndr Relat Disord; 2015 Jun; 13(5):208-13. PubMed ID: 25781493
[TBL] [Abstract][Full Text] [Related]
13. Metabolic Impact of Nonalcoholic Steatohepatitis in Obese Patients With Type 2 Diabetes.
Lomonaco R; Bril F; Portillo-Sanchez P; Ortiz-Lopez C; Orsak B; Biernacki D; Lo M; Suman A; Weber MH; Cusi K
Diabetes Care; 2016 Apr; 39(4):632-8. PubMed ID: 26861926
[TBL] [Abstract][Full Text] [Related]
14. Pancreatic fat and β-cell function in overweight/obese children with nonalcoholic fatty liver disease.
Pacifico L; Di Martino M; Anania C; Andreoli GM; Bezzi M; Catalano C; Chiesa C
World J Gastroenterol; 2015 Apr; 21(15):4688-95. PubMed ID: 25914480
[TBL] [Abstract][Full Text] [Related]
15. Roles of circulating WNT-signaling proteins and WNT-inhibitors in human adiposity, insulin resistance, insulin secretion, and inflammation.
Almario RU; Karakas SE
Horm Metab Res; 2015 Feb; 47(2):152-7. PubMed ID: 25089371
[TBL] [Abstract][Full Text] [Related]
16. Metabolic-associated fatty liver disease is characterized by a post-oral glucose load hyperinsulinemia in individuals with mild metabolic alterations.
Gignac T; Trépanier G; Pradeau M; Morissette A; Agrinier AL; Larose É; Marois J; Pilon G; Gagnon C; Vohl MC; Marette A; Carreau AM
Am J Physiol Endocrinol Metab; 2024 May; 326(5):E616-E625. PubMed ID: 38477665
[TBL] [Abstract][Full Text] [Related]
17. Circulating Retinol-Binding Protein 4 Is Inversely Associated With Pancreatic β-Cell Function Across the Spectrum of Glycemia.
Huang R; Yin S; Ye Y; Chen N; Luo S; Xia M; Zhao L
Diabetes Care; 2020 Jun; 43(6):1258-1265. PubMed ID: 32265192
[TBL] [Abstract][Full Text] [Related]
18. Dairy fat intake is associated with glucose tolerance, hepatic and systemic insulin sensitivity, and liver fat but not β-cell function in humans.
Kratz M; Marcovina S; Nelson JE; Yeh MM; Kowdley KV; Callahan HS; Song X; Di C; Utzschneider KM
Am J Clin Nutr; 2014 Jun; 99(6):1385-96. PubMed ID: 24740208
[TBL] [Abstract][Full Text] [Related]
19. Differential patterns of insulin secretion and sensitivity in patients with type 2 diabetes mellitus and nonalcoholic fatty liver disease versus patients with type 2 diabetes mellitus alone.
Chai SY; Pan XY; Song KX; Huang YY; Li F; Cheng XY; Qu S
Lipids Health Dis; 2014 Jan; 13():7. PubMed ID: 24397589
[TBL] [Abstract][Full Text] [Related]
20. GDF15 reflects beta cell function in obese patients independently of the grade of impairment of glucose metabolism.
Schernthaner-Reiter MH; Itariu BK; Krebs M; Promintzer-Schifferl M; Stulnig TM; Tura A; Anderwald CH; Clodi M; Ludvik B; Pacini G; Luger A; Vila G
Nutr Metab Cardiovasc Dis; 2019 Apr; 29(4):334-342. PubMed ID: 30718144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
